Theragen Etex Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,327
1,646
8,527
2,035
1,151
Depreciation, Depletion & Amortization
3,391
3,075
2,737
2,383
2,892
Other Funds
888
243
993
1,636
451
Funds from Operations
7,013
7,055
2,361
4,667
7,613
Changes in Working Capital
7,756
6,856
2,316
13,047
5,836
Net Operating Cash Flow
743
199
45
8,380
1,777
Capital Expenditures
3,965
2,239
12,132
11,706
3,176
Sale of Fixed Assets & Businesses
2
224
774
108
4
Purchase/Sale of Investments
7,029
3,145
5,897
804
3,252
Net Investing Cash Flow
10,684
5,919
3,156
11,829
8,738
Issuance/Reduction of Debt, Net
4,538
574
4,513
19,405
309
Net Financing Cash Flow
2,229
817
5,728
21,145
5,825
Net Change in Cash
9,486
4,904
2,677
887
1,206
Free Cash Flow
3,919
1,762
10,660
17,573
1,144
Net Assets from Acquisitions
-
-
263
5
-
Other Sources
1,186
491
4,603
3,044
4,393
Change in Capital Stock
5,880
-
222
103
5,065
Exchange Rate Effect
288
1
60
49
70
Other Uses
878
1,248
2,035
2,466
6,708

About Theragen Etex Co.

View Profile
Address
58 Sandan-ro 68beon-gil
Ansan-si GY 15438
Korea, Republic Of
Employees -
Website http://www.theragenetex.com
Updated 09/14/2018
THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the Pharmaceutical and Bio Businesses. The Pharmaceutical Business provides professional pharmaceutical products and new drugs development.